دورية أكاديمية

The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate cancer

التفاصيل البيبلوغرافية
العنوان: The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate cancer
المؤلفون: Saylor, Philip J., Kozin, Sergey V., Matsui, Aya, Goldberg, Saveli I., Aoki, Shuichi, Shigeta, Kohei, Mamessier, Emilie, Smith, Matthew R., Michaelson, M. Dror, Lee, Richard J., Duda, Dan G.
المصدر: In Radiotherapy and Oncology March 2024 192
قاعدة البيانات: ScienceDirect
الوصف
تدمد:01678140
DOI:10.1016/j.radonc.2024.110091